‘Pharmacy engagement in ICSs will be vital’
Community pharmacy should be involved in key decisions in neighbourhoods and systems to help reduce workload and increase patient access, a roundtable organized by...
Sanofi and GSK’s next-gen Covid booster jab ‘has potential against main variants’
French drugmaker Sanofi said on Monday (June 13) an upgraded version of the Covid-19 vaccine candidate it is developing with GSK showed potential in...
Pharmacy teams urged to sign up to ‘bold action’ on climate change
The Royal Pharmaceutical Society (RPS) and Pharmacy Declares are inviting pharmacy teams from around the world to sign up and commit to taking "bold...
EU disease prevention agency sees risk of Covid deaths rising as Omicron subvariants spread
Two new subvariants of Omicron -- BA.4 and BA.5 -- are spreading much faster than other corovanirus variants in Europe, which could lead to...
NICE recommends new treatment to prevent heart attacks, strokes in people with raised blood fats
The National Institute for Health and Care Excellence (NICE) has recommended icosapent ethyl also called Vazkepa manufactured by Amarin for adults who have cardiovascular...
How Technology Can Improve the Health Sector in Today’s Age
Are you looking for ways technology can improve the health sector? Technology has revolutionized every industry imaginable, so it's no surprise that it has...
Useful Tips On How To Choose Quality Supplements For You
When it comes to supplements, more and more people are starting to become interested in them. This is because supplements have a lot of...
‘Hub and spoke must benefit patient care’
While responding to the consultation on hub and spoke dispensing, trade unions for pharmacists have emphasized that the patient safety and care must be...
UKHSA advises self-isolation for people with monkeypox infection
The UK Health Security Agency (UKHSA) has advised self-isolation for people diagnosed with monkeypox to reduce the risk of spreading the infection.
Household members are...
GSK closer to cracking elusive vaccine for common respiratory virus
Pharmaceutical giant GlaxoSmithKline aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim data showed the...
Current Issue March 2024
